
|Articles|May 1, 2005
- Volume 0 0
Yoga May Relieve Insomnia
Advertisement
A preliminary study from Brigham and Women's Hospital, Harvard Medical School, showed thatyoga may help individuals with insomnia. During the study, participants with chronic insomnia didyoga daily. They also kept sleep—wake diaries over a 2-week baseline period and a 8-week subsequentintervention. A comparison of pretreatment and end treatment found that 20 participantsexhibited major improvements in sleep efficiency, total sleep time, total wake time, sleep onsetlatency, and wake time after sleep onset.
Articles in this issue
over 21 years ago
Top 200 Prescription Drugs of 2004over 21 years ago
New Drugs of 2004over 21 years ago
COMPOUNDING HOTLINEover 21 years ago
Avastin Decreases Lung Cancer Patients' Mortalityover 21 years ago
Simvastatin Improves Mortality of Heart Failure Patientsover 21 years ago
Pharma Companies Developing Antismoking Drugsover 21 years ago
Handbook Disclaimers Permit Dismissal of Pharmacistover 21 years ago
Annual Eye Exams Unnecessary for Someover 21 years ago
Safe Options for Needle Disposalover 21 years ago
Prevention Can Save $2.5 Billion AnnuallyAdvertisement
Related to this article

Pharmacists describe their experiences using DEA certificates for controlled substance prescribing in different practice settings, as well as barriers and opportunities for future expansion.

Professional membership and experienced mentor leadership offer new pharmacy technicians a dual advantage, serving as a comprehensive training accelerator.

A biologic stewardship framework can enhance consistency, safety, and sustainability of biologic use in health systems.

Artificial intelligence (AI) transforms a chaotic, reactive process into an adaptive, proactive system that improves workflow and patient safety.

Pharmacists are well equipped to manage DOAC therapy by providing initial education, adherence support, and safety monitoring.

Pharmacists play a key role in guiding age- and risk-based vaccination decisions to protect against invasive and noninvasive disease.

Peer Reviewed
Gepotidacin and zoliflodacin show comparable efficacy to standard care for urogenital gonorrhea, offering promising alternatives given the recent rise in antimicrobial resistance.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Adult Pneumococcal Immunizations: A Practical Guide for Pharmacists
2
FDA Approves Rebisufligene Etisparvovec as First Gene Therapy for Children With Sanfilippo Syndrome Type A
3
FDA Reduces Monitoring Time for First Two Tarlatamab Doses
4
Radioligand Therapy Doesn’t Need to Be Risk-Free—It Needs to Be Worth It
5

